C07K 2319/095
Containing a nuclear export signal
Official title: containing a nuclear export signal
C07K2319/095 (Containing a nuclear export signal) appears on 36 US grants and 86 published applications in this corpus.
Search patents in C07K- Granted patents
- 36
- Published applications
- 86
- Assignees
- 45
- Inventors
- 179
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 1 | 2 |
| 2016 | 3 | 9 |
| 2017 | 3 | 5 |
| 2018 | 5 | 5 |
| 2019 | 3 | 2 |
| 2020 | 2 | 1 |
| 2021 | 2 | 5 |
| 2022 | 1 | 9 |
| 2023 | 3 | 6 |
| 2024 | 4 | 11 |
| 2025 | 5 | 15 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions to spread protein cargoes across multi-nucleated cells23 Jun 2026US 12,662,517 B2University of Florida Research Foundation, Inc.
- RNA programmable epigenetic RNA modifiers and uses thereof13 Jan 2026US 12,522,807 B2President and Fellows of Harvard College
- CRISPR having or associated with destabilization domains7 Oct 2025US 12,435,320 B2Massachusetts Institute of Technology
- Cytosine to guanine base editor7 Oct 2025US 12,435,331 B2President and Fellows of Harvard College
- Molecules for organelle-specific protein delivery8 Jul 2025US 12,351,611 B2Larimar Therapeutics, Inc.
- Methods and compositions to spread protein cargoes across multi-nucleated cells24 Sep 2026US 2026/0285925 A1University of Florida Research Foundation, Inc.
- Cas13 protein, and crispr-cas system, and use thereof24 Sep 2026US 2026/0286328 A1Yoltech Therapeutics Co., Ltd
- Method for controlling intracellular localization of sgrna and regulating gene expression24 Sep 2026US 2026/0286351 A1Guangzhou Medical University
- EvolvR Polypeptides and Methods of Use Thereof23 Jul 2026US 2026/0209758 A1
- Crispr having or associated with destabilization domains4 Jun 2026US 2026/0152731 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Cytosine to guanine base editor43US 11,542,496 B2President and Fellows of Harvard College · 2023
- CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes21US 10,377,998 B2Massachusetts Institute of Technology · 2019
- CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes11US 11,149,259 B2Massachusetts Institute of Technology · 2021
- Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation11US 11,578,312 B2Massachusetts Institute of Technology · 2023
- Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses8US 9,481,714 B2TheVax Genetics Vaccine Co., Ltd. · 2016